It has gained significant attention in research communities focused on cognitive peptide research
How GLP-1 receptor agonists work GLP-1 receptor agonists mimic the action of the GLP-1 hormone, which is naturally produced in the gut
An infectious cDNA clone of SARS-CoV-2
Recent technology, such as nanomedicine, further enhances tripeptide effects in many therapies
Current clinical programs are investigating how microdosing GLP-1s may help treat early metabolic dysfunction (like in perimenopause) and help minimize the common side effects associated with higher doses
A concise JAMA Insights piece by Kushner, Jastreboff, and Ryan highlights how todays leading agentssemaglutide (GLP-1RA) and tirzepatide (GIP/GLP-1RA)are already delivering ~15% and ~21% mean weight reduction, respectively, while improving cardiometabolic risk markers and related outcomes